Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
- PMID: 33596811
- DOI: 10.2174/1871520621666210217094839
Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Abstract
MiRNAs that are characterized by small non-coding RNAs orchestrate the expression of important genes involved in cancer cell development processes, including apoptosis, proliferation, angiogenesis, metastasis, and drug resistance at the post-transcriptional level. Dysregulation of miR-9 in various cancers has been reported. Recently, miR-9 has been considered as a key miRNA in various malignancies. However, its importance in the pathogenesis of different neoplasms is not yet well defined. Accordingly, this study was conducted in order to clarify the potential roles of miR-9 in the development of various cancers, prognosis, and treatment approaches. We have shown that a large number of miR-9 targets play fundamental roles in carcinogenesis, and that is dysregulated in various cancer cells. Our findings werefound aberrant miR-9 expression in a majority of cancers. This review article generally emphasizesthe critical roles of miR-9 in cancer cell progression. Additionally, we intended to investigate the effects of down-regulation or up-regulation of miR-9 in different types of cancers. It is hoped that a good understanding of the regulatory roles of miR-9 in various cancers ishelpful for using miR-9 in clinical settings, including prognosis, diagnosis, and miRNA-based target therapy.
Keywords: Angiogenesis; cancer; drug resistance; miR-9; proliferation.; signaling pathway.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.Oncotarget. 2015 Mar 30;6(9):6472-98. doi: 10.18632/oncotarget.3052. Oncotarget. 2015. PMID: 25762624 Free PMC article. Review.
-
The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target.Curr Cancer Drug Targets. 2014;14(7):621-37. doi: 10.2174/156800961407140926105634. Curr Cancer Drug Targets. 2014. PMID: 25308719 Review.
-
miRNA and cancer; computational and experimental approaches.Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335. Curr Pharm Biotechnol. 2014. PMID: 25189575
-
MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers.Mol Biotechnol. 2024 Jul;66(7):1537-1551. doi: 10.1007/s12033-023-00756-5. Epub 2023 Jun 19. Mol Biotechnol. 2024. PMID: 37332071 Review.
-
MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment.Cell Physiol Biochem. 2016;39(6):2186-2202. doi: 10.1159/000447913. Epub 2016 Nov 2. Cell Physiol Biochem. 2016. PMID: 27802440 Review.
Cited by
-
miR-375 suppresses the growth and metastasis of esophageal squamous cell carcinoma by targeting PRDX1.J Gastrointest Oncol. 2022 Oct;13(5):2154-2168. doi: 10.21037/jgo-22-929. J Gastrointest Oncol. 2022. PMID: 36388649 Free PMC article.
-
Role of miRNA-495 and NRXN-1 and CNTN-1 mRNA Expression and Its Prognostic Importance in Breast Cancer Patients.J Oncol. 2021 Oct 8;2021:9657071. doi: 10.1155/2021/9657071. eCollection 2021. J Oncol. 2021. PMID: 34659414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical